BeiGene Ltd. (BGNE) Dividend History

BeiGene Ltd is a clinical-stage biopharmaceutical company engaged in the discovery & development of molecularly targeted & immuno-oncology drugs for the treatment of cancer. Its product includes BGB-3111, BGB-283 and BGB-290 and one immuno-oncology agent.

Last update 12/14/2019


Dividend Yield Summary

  2014 2015 2016 2017 2018 2019
Dividends - - - - - -
Average Price - - 29.64 60.57 153.88 138.76
Yield - - - - - -
• The above Dividend, Average Price, and Yield values for 2019 are year-to-date.

Dividend History

No history of dividends
Date Amount Per Share Note
What other features would you like to see on this site? Please send us your comments: